| Number of Patients, Male | 32 |
| Number of Patients, Female | 7 |
| Stage | Stage II: 1 (2.6%); stage IIIA: 14 (35.9%); stage IIIB: 3 (7.7%); stage IIIC 4 (10.3%); stage IV 17 (43.6%) |
| Age | Median (range): 54 (32–75) years |
| Number of Prior Systemic Therapies | Median (range): 1 (0–3) |
| Performance Status: ECOG |
0 — 0 1 — 39 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes |
Hepatocellular carcinoma: 39 Hepatocellular carcinoma + HBV: 27 Hepatocellular carcinoma + hepatitis C virus: 7 Hepatocellular carcinoma + HBV + hepatitis C virus: 5 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.